![]() |
|
|
Vol. 62, Issue 1, 22-29, July 2002
Nervous System Research, Novartis Pharma Ltd., Basel, Switzerland
(P.C.W., J.-J.F.); and Department of Cell and Developmental Biology,
University of North Carolina, Chapel Hill, North Carolina (T.Q.,
J.J.L.)
Cyclosporin A (CsA) shows cytoprotective properties in many cellular
and in vivo models that may depend on interference of the interaction
of cyclophilin A with calcineurin or of cyclophilin D with the
mitochondrial permeability transition (PT) pore. The nonimmunosuppressive cyclosporin derivative
N-methyl-4-valine-cyclosporin (PKF220-384) inhibits the
mitochondrial permeability transition (MPT) like CsA but without
calcineurin inactivation. PKF220-384 has been used to discriminate
between PT pore- and calcineurin mediated effects but is no longer
available. Here, we evaluated the effects of another
nonimmunosuppressive cyclosporin derivative, N-methyl-4-isoleucine-cyclosporin (NIM811) on the MPT.
Using two newly developed microtiter plate assays, one measuring
mitochondrial swelling from absorbance and the other measuring
mitochondrial membrane potential from changes in safranin fluorescence,
we show that NIM811 blocks the MPT induced by calcium and inorganic
phosphate, alone or in combination with the dopaminergic neurotoxin
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, the complex I inhibitor
rotenone, and the prooxidant t-butylhydroperoxide. NIM811 was equipotent to CsA and half as potent as PKF220-384. Additionally, we show that NIM811 blocks cell killing and prevents in
situ mitochondrial inner membrane permeabilization and depolarization during tumor necrosis factor-
-induced apoptosis to cultured rat hepatocytes. NIM811 inhibition of apoptosis was equipotent with CsA
except at higher concentrations: CsA lost efficacy but NIM 811 did not.
We conclude that NIM811 is a useful alternative to PKF220-384 to
investigate the role of the mitochondrial permeability transition in
apoptotic and necrotic cell death.
This article has been cited by other articles:
![]() |
S. E. McAllister, H. Ashrafpour, N. Cahoon, N. Huang, M. A. Moses, P. C. Neligan, C. R. Forrest, J. E. Lipa, and C. Y. Pang Postconditioning for salvage of ischemic skeletal muscle from reperfusion injury: efficacy and mechanism Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R681 - R689. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Wallace Mitochondria as Chi Genetics, June 1, 2008; 179(2): 727 - 735. [Full Text] [PDF] |
||||
![]() |
L. Argaud, O. Gateau-Roesch, L. Augeul, E. Couture-Lepetit, J. Loufouat, L. Gomez, D. Robert, and M. Ovize Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H386 - H391. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shalbuyeva, T. Brustovetsky, A. Bolshakov, and N. Brustovetsky Calcium-dependent Spontaneously Reversible Remodeling of Brain Mitochondria J. Biol. Chem., December 8, 2006; 281(49): 37547 - 37558. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Kim, Y. Jin, and J. J. Lemasters Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2024 - H2034. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Krolikowski, M. Bienengraeber, D. Weihrauch, D. C. Warltier, J. R. Kersten, and P. S. Pagel Inhibition of Mitochondrial Permeability Transition Enhances Isoflurane-Induced Cardioprotection During Early Reperfusion: The Role of Mitochondrial KATP Channels Anesth. Analg., December 1, 2005; 101(6): 1590 - 1596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Davies, S. B. Digerness, C. R. Killingsworth, C. Zaragoza, C. R. Katholi, R. K. Justice, S. P. Goldberg, and W. L. Holman Multiple Treatment Approach to Limit Cardiac Ischemia-Reperfusion Injury Ann. Thorac. Surg., October 1, 2005; 80(4): 1408 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Argaud, O. Gateau-Roesch, O. Raisky, J. Loufouat, D. Robert, and M. Ovize Postconditioning Inhibits Mitochondrial Permeability Transition Circulation, January 18, 2005; 111(2): 194 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Argaud, O. Gateau-Roesch, L. Chalabreysse, L. Gomez, J. Loufouat, F. Thivolet-Bejui, D. Robert, and M. Ovize Preconditioning delays Ca2+-induced mitochondrial permeability transition Cardiovasc Res, January 1, 2004; 61(1): 115 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Bouchard, R. J. Puro, L. Wang, and R. J. Schneider Activation and Inhibition of Cellular Calcium and Tyrosine Kinase Signaling Pathways Identify Targets of the HBx Protein Involved in Hepatitis B Virus Replication J. Virol., July 15, 2003; 77(14): 7713 - 7719. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-W. Oh, T. Qian, D. A. Brenner, and J. J. Lemasters Salicylate Enhances Necrosis and Apoptosis Mediated by the Mitochondrial Permeability Transition Toxicol. Sci., May 1, 2003; 73(1): 44 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Castedo, J.-L. Perfettini, and G. Kroemer Mitochondrial Apoptosis and the Peripheral Benzodiazepine Receptor: A Novel Target for Viral and Pharmacological Manipulation J. Exp. Med., November 4, 2002; 196(9): 1121 - 1126. [Full Text] [PDF] |
||||